Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype.

Journal Article (Journal Article)

[Figure: see text].

Full Text

Duke Authors

Cited Authors

  • Piccini, JP; Dufton, C; Carroll, IA; Healey, JS; Abraham, WT; Khaykin, Y; Aleong, R; Krueger, SK; Sauer, WH; Wilton, SB; Rienstra, M; van Veldhuisen, DJ; Anand, IS; White, M; Camm, AJ; Ziegler, PD; Marshall, D; Bristow, MR; Connolly, SJ; Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Atrial Fibrillation/Atrial Flutter in Patients with Heart Failure Trial Investigators*,

Published Date

  • August 2021

Published In

Volume / Issue

  • 14 / 8

Start / End Page

  • e009591 -

PubMed ID

  • 34270905

Electronic International Standard Serial Number (EISSN)

  • 1941-3084

Digital Object Identifier (DOI)

  • 10.1161/CIRCEP.120.009591


  • eng

Conference Location

  • United States